These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27569051)

  • 1. Comparison of various in vitro model systems of the metabolism of synthetic doping peptides: Proteolytic enzymes, human blood serum, liver and kidney microsomes and liver S9 fraction.
    Zvereva I; Semenistaya E; Krotov G; Rodchenkov G
    J Proteomics; 2016 Oct; 149():85-97. PubMed ID: 27569051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro models for metabolic studies of small peptide hormones in sport drug testing.
    Esposito S; Deventer K; Geldof L; Van Eenoo P
    J Pept Sci; 2015 Jan; 21(1):1-9. PubMed ID: 25469748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic in vitro metabolism of peptides; Comparison of human liver S9, hepatocytes and Upcyte hepatocytes with cyclosporine A, leuprorelin, desmopressin and cetrorelix as model compounds.
    Jyrkäs J; Tolonen A
    J Pharm Biomed Anal; 2021 Mar; 196():113921. PubMed ID: 33548873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrahepatic in vitro metabolism of peptides; comparison of human kidney and intestinal S9 fraction, human plasma and proximal tubule cells, using cyclosporine A, leuprorelin, and cetrorelix as model compounds.
    Jyrkäs J; Lassila T; Tolonen A
    J Pharm Biomed Anal; 2023 Feb; 225():115219. PubMed ID: 36630767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic study of androsta-1,4,6-triene-3,17-dione in horses using liquid chromatography/high resolution mass spectrometry.
    Kwok WH; Leung GN; Wan TS; Curl P; Schiff PJ
    J Steroid Biochem Mol Biol; 2015 Aug; 152():142-54. PubMed ID: 26031748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro metabolism of perospirone in rat, monkey and human liver microsomes.
    Mizuno Y; Tani N; Komuro S; Kanamaru H; Nakatsuka I
    Eur J Drug Metab Pharmacokinet; 2003; 28(1):59-65. PubMed ID: 14503666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of growth hormone releasing peptides.
    Thomas A; Delahaut P; Krug O; Schänzer W; Thevis M
    Anal Chem; 2012 Dec; 84(23):10252-9. PubMed ID: 23101768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of metabolites of peptide-derived drugs using an isotope-labeled reporter ion screening strategy.
    Thomas A; Thevis M
    Clin Chem Lab Med; 2020 Apr; 58(5):690-700. PubMed ID: 31860462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometric studies on the in vivo metabolism and excretion of SIRT1 activating drugs in rat urine, dried blood spots, and plasma samples for doping control purposes.
    Höppner S; Delahaut P; Schänzer W; Thevis M
    J Pharm Biomed Anal; 2014 Jan; 88():649-59. PubMed ID: 24239904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel growth hormone releasing peptide (a glycine analogue of GHRP-2) in a seized injection vial.
    Popławska M; Błażewicz A
    Drug Test Anal; 2019 Jan; 11(1):162-167. PubMed ID: 30051972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nonradioactive approach to investigate the metabolism of therapeutic peptides by tagging with 127i and using inductively-coupled plasma mass spectrometry analysis.
    Lim HK; Cao Y; Qiu X; Silva J; Evans DC
    Drug Metab Dispos; 2015 Jan; 43(1):17-26. PubMed ID: 25315343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro metabolism of the REV-ERB agonist SR-9009 and subsequent detection of metabolites in associated routine equine plasma and urine doping control samples.
    Cutler C; White DL; Viljanto M
    Drug Test Anal; 2022 Jan; 14(1):169-174. PubMed ID: 34224639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of GSH-trapped reactive metabolites in human liver microsomes, S9 fraction, HepaRG-cells, and human hepatocytes.
    Lassila T; Rousu T; Mattila S; Chesné C; Pelkonen O; Turpeinen M; Tolonen A
    J Pharm Biomed Anal; 2015 Nov; 115():345-51. PubMed ID: 26263063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of in vitro synthesised metabolites of 4,9,11-trien-3-one steroids by liquid chromatography mass spectrometry.
    Kuuranne T; Pystynen KH; Thevis M; Leinonen A; Schänzer W; Kostiainen R
    Eur J Mass Spectrom (Chichester); 2008; 14(3):181-9. PubMed ID: 18708698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the metabolites of the HIF stabilizer FG-4592 (roxadustat) in five different in vitro models and in a human doping control sample using high resolution mass spectrometry.
    Hansson A; Thevis M; Cox H; Miller G; Eichner D; Bondesson U; Hedeland M
    J Pharm Biomed Anal; 2017 Feb; 134():228-236. PubMed ID: 27918992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry.
    Thomas A; Höppner S; Geyer H; Schänzer W; Petrou M; Kwiatkowska D; Pokrywka A; Thevis M
    Anal Bioanal Chem; 2011 Aug; 401(2):507-16. PubMed ID: 21298258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study on the in vitro biotransformation of medicagenic acid using human liver microsomes and S9 fractions.
    Peeters L; Vervliet P; Foubert K; Hermans N; Pieters L; Covaci A
    Chem Biol Interact; 2020 Sep; 328():109192. PubMed ID: 32712081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotransformation of bisphenol F by human and rat liver subcellular fractions.
    Cabaton N; Zalko D; Rathahao E; Canlet C; Delous G; Chagnon MC; Cravedi JP; Perdu E
    Toxicol In Vitro; 2008 Oct; 22(7):1697-704. PubMed ID: 18672047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic characterization of (±)-praeruptorin A in vitro and in vivo by high performance liquid chromatography coupled with hybrid triple quadrupole-linear ion trap mass spectrometry and time-of-flight mass spectrometry.
    Song YL; Jing WH; Yan R; Wang YT
    J Pharm Biomed Anal; 2014 Mar; 90():98-110. PubMed ID: 24342524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.